1H-Pyrazolo[3,4-b]quinoxalin-3-amine,
40254-90-8,
3-Amino-1H-pyrazolo[3,4-b]quinoxaline,
Cdk1/5 Inhibitor,
Quinoxaline1,
NSC 693868,
2H-PYRAZOLO[3,4-B]QUINOXALIN-3-AMINE,
2H-pyrazolo[4,3-b]quinoxalin-3-amine,
56984-56-6,
quinoxaline 1,
Tocris-1937,
K00033,
AC1L96GN,
BDBM7534,
CHEMBL259389,
GTPL5947,
SCHEMBL1394500,
CHEBI:92540,
CTK1D5328,
CTK5A6106,
DWHVZCLBMTZRQM-UHFFFAOYSA-N,
HMS3229C18,
HMS3268M10,
HMS3676L20,
ZINC5543794,
FCH848632,
HSCI1_000152,
NSC693868,
AKOS006293899,
AKOS024456869,
AKOS030537560,
pyrazolo[3,4-b]quinoxaline deriv. 1,
CCG-206825,
NSC-693868,
ACM40254908,
NCGC00025317-01,
NCI60_033600,
B6892,
FT-0645277,
2H-Pyrazolo[3,4-b]quinoxalin-3-amine(9CI),
SR-01000597549,
3-amino-1H-pyrazolo[3,4-b]quinoxaline, AldrichCPR,
SR-01000597549-1,
BRD-K31268420-001-01-1,
BRD-K87932577-001-01-6,
D0R5FH,
CID438981,